Ask The Experts
In The Blogs
Video Vault
 |
Drug Delivery
Promoting Patient Safety through Product Quality
Deck:
At Pharmapack Europe, next-generation packaging technology seeks to address drug makers’ concerns about contamination.
Speakers and exhibitors at Pharmapack Europe February 15-16 will be focusing on easing drug delivery while overcoming industry’s challenges.
|
Can’t Make It to Europe? Don't Miss the Pharmapack Europe ConferencePlan now to visit Pharmapack Europe in Paris February 15-16. For more details on the event, visit www.pharmapack.fr. Hope to see you stop by the PMP News booth! Wednesday 15th February 2012 Did You Read Our Most Popular Articles from 2011?As we celebrate the end of 2011, we'd like to take time to point out the year's top articles on www.pmpnews.com. Following are the articles published this year that drew the most page views. Gebauer Unveils Spray SystemGebauer Company (www.gebauer.com) has launched the Accu-Stream 360 with Sure Lock Technology to enhance the delivery of its ethyl chloride topical anesthetic skin refrigerant. The system uses 45mm slim containers from Crown Aerosol Packaging North America, a business unit of Crown Holdings, Inc., aerosol valves from Aptar Cary, a business unit of Aptargroup, Inc., and actuators designed jointly by Gebauer and Venture Plastics, Inc. and manufactured by Venture Plastics.
“Ouch less” Vaccine DeliveryWith the launch of the Fluzone Intradermal influenza virus vaccine, Sanofi Pasteur has provided a new option for vaccine administration in the United States. The first flu vaccine using a microinjection system for intradermal delivery in the United States, Fluzone Intradermal is indicated for adults ages 18 to 64, an age group with traditionally low rates of immunization.
The system features an integrated ultra-fine 0.06-in.
Pulmatrix Offers Dry Powder PlatformPulmatrix (www.pulmatrix.com), a clinical stage biotech company, has launched the iSPERSE inhaled dry powder drug delivery platform. iSPERSE’s proprietary cationic salt formulations are spray dried together with a drug or drug combinations to produce dry powders optimized for inhalation that are small in particle size, relatively dense, and highly dispersible.
The iSPERSE technology enables loading more drug into a dose and is relatively independent of flow rate.
Tapemark Expands In Active Transdermal SystemsTapemark (www.tapemark.com) has expanded its presence in the active transdermal systems business in acquiring Travanti Pharma Inc.’s IontoPatch business and a suite of iontophoretic technology (www.iontopatch.com), to be distributed through a newly formed entity called Travanti Medical.
“This acquisition was a natural extension for Tapemark. With our experience in both passive and active transdermal drug delivery, we continue to see transdermal systems as a growth area,” says Andy Rensink, president and COO, Tapemark.
New Routes in Dosing
Among new options, Catalent adds controlled-release and quick-dissolve formats.
Controlled-release and fast-dissolve technologies have expanded the possibilities of solid-dose delivery.
Merck Serono to Use Haselmeier Self-Injection TechnologyThe Axis-D pen from Haselmeier GmbH is to be used by Merck Serono, a division of Merck KGaA, Germany. Haselmeier designs and manufactures pen and auto-injection systems designed to allow self injection by patients of a ready-to-use biopharmaceutical solution. Transdermal Delivery Market Predicted to Reach $31.5 Billion by 2015: PharmaLive Special ReportThe transdermal delivery market was valued at $21.5 billion in 2010 and is predicted to reach $31.5 billion by 2015. The annual U.S. market for transdermal patches is estimated at more than $3 billion. Transdermal drugs account for more than 12% of the global drug delivery market. 
Daily BuzzWho's online
There are currently 0 users and 210 guests online.
Media Kit | Privacy Policy | Contact | Feedback | Advertise | Subscribe | Qmed - Medical Devices | Packaging Digest | Sitemap |
